DK261386D0 - Monoklonale antistoffer - Google Patents

Monoklonale antistoffer

Info

Publication number
DK261386D0
DK261386D0 DK261386A DK261386A DK261386D0 DK 261386 D0 DK261386 D0 DK 261386D0 DK 261386 A DK261386 A DK 261386A DK 261386 A DK261386 A DK 261386A DK 261386 D0 DK261386 D0 DK 261386D0
Authority
DK
Denmark
Prior art keywords
cyclosporine
monoclonal antibodies
succinimidooxysuccinyl
cyclosporins
conjugates
Prior art date
Application number
DK261386A
Other languages
English (en)
Other versions
DK261386A (da
DK172037B1 (da
Inventor
Joachim Rosenthaler
Roland Wenger
Philipp E Ball
Max H Schreier
Valerie Quesniaux
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848425040A external-priority patent/GB8425040D0/en
Priority claimed from GB858515673A external-priority patent/GB8515673D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK261386D0 publication Critical patent/DK261386D0/da
Publication of DK261386A publication Critical patent/DK261386A/da
Application granted granted Critical
Publication of DK172037B1 publication Critical patent/DK172037B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
DK261386A 1984-10-04 1986-06-03 Monoklonale antistoffer med cyclosporiner, hybridomcellelinje og immunoassaykit eller -system DK172037B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8425040 1984-10-04
GB848425040A GB8425040D0 (en) 1984-10-04 1984-10-04 Organic compounds
GB8515673 1985-06-20
GB858515673A GB8515673D0 (en) 1985-06-20 1985-06-20 Organic compounds
PCT/EP1985/000501 WO1986002080A1 (en) 1984-10-04 1985-09-27 Monoclonal antibodies to cyclosporings
EP8500501 1985-09-27

Publications (3)

Publication Number Publication Date
DK261386D0 true DK261386D0 (da) 1986-06-03
DK261386A DK261386A (da) 1986-06-03
DK172037B1 DK172037B1 (da) 1997-09-22

Family

ID=26288301

Family Applications (1)

Application Number Title Priority Date Filing Date
DK261386A DK172037B1 (da) 1984-10-04 1986-06-03 Monoklonale antistoffer med cyclosporiner, hybridomcellelinje og immunoassaykit eller -system

Country Status (15)

Country Link
EP (4) EP0314862A1 (da)
JP (1) JPH074269B2 (da)
KR (1) KR910002691B1 (da)
AT (1) ATE92501T1 (da)
AU (4) AU589917B2 (da)
CA (1) CA1309671C (da)
CY (2) CY1915A (da)
DE (2) DE3587342T2 (da)
DK (1) DK172037B1 (da)
ES (1) ES8702949A1 (da)
FI (1) FI93965C (da)
HK (2) HK78696A (da)
NO (1) NO173557C (da)
NZ (1) NZ213680A (da)
WO (1) WO1986002080A1 (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0283801A3 (en) * 1987-03-27 1990-05-30 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
US5239057A (en) * 1987-03-27 1993-08-24 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
US5427960A (en) * 1987-03-27 1995-06-27 Abbott Laboratories Fluorescence polarization assay for cyclosporin A and metabolites and related immunogens and antibodies
US5698448A (en) * 1988-12-02 1997-12-16 Soldin; Steven J. Immunosuppressive drug binding proteins and use
AU4958590A (en) * 1988-12-05 1990-07-10 Trustees Of Columbia University In The City Of New York, The Novel derivatives of cyclosporine a, antibodies directed thereto and uses thereof
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
CA2048302A1 (en) * 1990-08-15 1992-02-16 Victoria P. Meucci Solubilization reagent for biological test samples
EP0473961B1 (en) * 1990-08-15 1996-01-03 Abbott Laboratories Immunoassay reagents and method for determining cyclosporine
ES2091301T3 (es) 1990-11-20 1996-11-01 Behringwerke Ag Inmunoensayo de ciclosporina.
USRE40596E1 (en) * 1993-04-08 2008-12-02 Novartis Ag Rapamycin assay
GB9307491D0 (en) 1993-04-08 1993-06-02 Sandoz Ltd Organic compounds
AU8918998A (en) 1997-08-26 1999-03-16 Wisconsin Alumni Research Foundation Non-immunosuppressive cyclosporins and their use in the prevention and treatmentof hiv infection
US6270957B1 (en) 1997-08-26 2001-08-07 Wisconsin Alumni Research Foundation Non-Imuunosuppressive cyclosporins and their use in the prevention and treatment of HIV infection
US5990274A (en) * 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
ATE312843T1 (de) 1998-07-01 2005-12-15 Debiopharm Sa Neues cyclosporin mit verbesserter wirkung
US6686454B1 (en) 1998-10-09 2004-02-03 Isotechnika, Inc. Antibodies to specific regions of cyclosporine related compounds
CN1319105A (zh) 1998-10-09 2001-10-24 伊索技术公司 制备针对环孢菌素及其代谢物特异性区域的抗体的方法
WO2003033526A2 (en) 2001-10-19 2003-04-24 Isotechnika Inc. Synthesis of cyclosporin analogs
EP2174137B1 (en) 2007-05-24 2011-11-30 Abbott Laboratories Immunoassays exhibiting reduced cross-reactivity with hydrophobic drug analyte metabolites
TW200932240A (en) 2007-10-25 2009-08-01 Astellas Pharma Inc Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
WO2009141738A2 (en) * 2008-05-23 2009-11-26 The University Of British Columbia Modified drugs for use in liposomal nanoparticles
EP2391376A4 (en) 2009-01-30 2012-08-01 Enanta Pharm Inc ANALOGUES OF CYCLOSPORIN FOR PREVENTING OR TREATING HEPATITIS C INFECTION
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8367053B2 (en) 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8349312B2 (en) 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
US8685917B2 (en) 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8623814B2 (en) 2010-02-23 2014-01-07 Enanta Pharmaceuticals, Inc. Antiviral agents
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
WO2012145426A1 (en) 2011-04-18 2012-10-26 The Trustees Of Columbia University In The City Of New York Methods to treat cancer using cyclosporine and cyclosporine derivatives
WO2014085623A1 (en) 2012-11-28 2014-06-05 Enanta Pharmaceuticals, Inc. Novel [n-me-4-hydroxyleucine]-9-cyclosporin analogues
CN105579046A (zh) 2013-08-26 2016-05-11 英安塔制药有限公司 用于预防或治疗丙型肝炎的环孢菌素类似物
US9669095B2 (en) 2014-11-03 2017-06-06 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis C infection
EP3247378B8 (en) 2015-01-09 2023-08-23 Revolution Medicines, Inc. Macrocyclic compounds that participate in cooperative binding and medical uses thereof
JP7411326B2 (ja) 2015-10-01 2024-01-11 ワープ ドライブ バイオ インコーポレイテッド タンパク質－タンパク質インターフェースを分析するための方法および試薬
ES2921056T3 (es) 2016-04-12 2022-08-17 Warp Drive Bio Inc Composiciones y métodos para la producción de compuestos
CA3042231A1 (en) 2016-10-28 2018-05-03 Ginkgo Bioworks, Inc. Compositions and methods for the production of compounds
AU2020379731A1 (en) 2019-11-04 2022-05-05 Revolution Medicines, Inc. Ras inhibitors
EP4055028A1 (en) 2019-11-04 2022-09-14 Revolution Medicines, Inc. Ras inhibitors
MX2022005359A (es) 2019-11-04 2022-06-02 Revolution Medicines Inc Inhibidores de ras.
KR20230067635A (ko) 2020-09-15 2023-05-16 레볼루션 메디슨즈, 인크. 암의 치료에서 ras 억제제로서 인돌 유도체

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB211526A (en) 1922-09-22 1924-02-22 John Fletcher Holliday Improvements in and relating to chain grate stokers
US4210581A (en) 1975-11-04 1980-07-01 Sandoz Ltd. Organic compounds
CH614931A5 (da) 1975-11-04 1979-12-28 Sandoz Ag
DE2819094A1 (de) 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
EP0098457B1 (en) 1980-02-14 1987-08-05 Sandoz Ag (1s,2r,3r)- and (1r,2s,3s)-nitrilo-1-carbonyl-3-methyl-2-oxy-heptanes and -hept-5-enes useful in the total synthesis of cyclosporins and processes for their production
IL62965A0 (en) 1980-07-17 1981-07-31 Scripps Miles Lab Inc Monoclonal antibodies to drugs and theri production
EP0056782B1 (en) 1981-01-09 1984-08-01 Sandoz Ag Novel cyclosporins
GB8407618D0 (en) 1984-03-23 1984-05-02 Sandoz Ltd Organic compounds
CH667274A5 (de) 1984-03-23 1988-09-30 Sandoz Ag Cyclosporine, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Also Published As

Publication number Publication date
FI93965C (fi) 1995-06-26
AU589917B2 (en) 1989-10-26
FI862370A0 (fi) 1986-06-03
EP0198026A1 (en) 1986-10-22
EP0314861A1 (en) 1989-05-10
CY1927A (en) 1997-05-16
EP0290762A1 (en) 1988-11-17
JPS62500383A (ja) 1987-02-19
DE3587342T2 (de) 1993-12-02
AU3914189A (en) 1989-11-16
NO862177D0 (no) 1986-06-02
WO1986002080A1 (en) 1986-04-10
ES8702949A1 (es) 1987-01-16
AU3914289A (en) 1989-10-26
NO862177L (no) 1986-08-04
NO173557B (no) 1993-09-20
FI93965B (fi) 1995-03-15
AU3914389A (en) 1989-11-16
EP0198026B1 (en) 1993-08-04
CA1309671C (en) 1992-11-03
KR910002691B1 (ko) 1991-05-03
JPH074269B2 (ja) 1995-01-25
ES547495A0 (es) 1987-01-16
DK261386A (da) 1986-06-03
ATE92501T1 (de) 1993-08-15
NO173557C (no) 1993-12-29
DE3587505D1 (de) 1993-09-09
FI862370A (fi) 1986-06-03
HK124696A (en) 1996-07-19
EP0290762B1 (en) 1993-05-12
KR870700637A (ko) 1987-12-30
DE3587505T2 (de) 1994-01-05
DE3587342D1 (en) 1993-06-17
NZ213680A (en) 1990-05-28
CY1915A (en) 1985-09-27
EP0314862A1 (en) 1989-05-10
AU4967185A (en) 1986-04-17
HK78696A (en) 1996-05-10
DK172037B1 (da) 1997-09-22

Similar Documents

Publication Publication Date Title
DE3587342T2 (de) Cyclosporine.
ES2091301T3 (es) Inmunoensayo de ciclosporina.
MY104946A (en) Antigen antibody conjugate.
CA2267072A1 (en) Reconstituted human anti-hm1.24 antibody
AU1520895A (en) Purified primate ctla-8 antigens and related reagents
HK1023513A1 (en) Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods
ES2123677T3 (es) Ligadores de maleinimida trifuncionales homobidentados y su uso en conjugados inmunologicamente activos.
DE69637524D1 (de) Das h-y antigen
AU576088B2 (en) Histamine derivatives, immunogen conjugates and antibodies raised thereto
EP1026237A3 (en) Tau/neurofilament protein kinases pk40 & pk36
AU7796291A (en) High affinity antibodies to small peptides
IL77862A (en) Enzymatic immunoassay to determine the amount of antibodies to htlv-iii and test kit
AU4543185A (en) Molecule comprising at least one peptidic sequence carrying an epitope
AU5771798A (en) Antigen
RO89316A2 (ro) Hibrid triliniar de porumb(zea mays l.convar.indurata)"podu iloaiei 101"

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired